March 8, 2021Marshall Gerstein client Onyx Therapeutics prevails on appeal before Federal Circuit in case about Kyprolis® (carfilzomib) product More
Please note that email communications sent through this website do not create an attorney-client relationship between you and our firm, and will not prevent us from representing another person or company involved in the same matter that is the subject of your message. Unless you are already a client of Marshall, Gerstein & Borun LLP, do not send any information that you consider privileged or confidential. Click “Accept” below to confirm that you have read and understand this message.
By clicking “Proceed” below, you will be opening a new browser window and leaving our website.